Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.

Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, Sujit SJ, Lu X, Young E, Al-Tashi Q, Qureshi R, Wu CC, Carter BW, Lin SH, Lee PP, Gandhi S, Chang JY, Li R, Gensheimer MF, Wakelee HA, Neal JW, Lee HS, Cheng C, Velcheti V, Lou Y, Petranovic M, Rinsurongkawong W, Le X, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Antonoff MB, Sepesi B, Lewis J, Wistuba II, Hazle JD, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee JJ, Heymach JV, Zhang J, Wu J

Open source

DOI
10.1016/s2589-7500(23)00082-1
Published
2023 Jul
Container
The Lancet. Digital health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2589-7500-23-00082-1,
  title = {Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.},
  author = {Saad MB and Hong L and Aminu M and Vokes NI and Chen P and Salehjahromi M and Qin K and Sujit SJ and Lu X and Young E and Al-Tashi Q and Qureshi R and Wu CC and Carter BW and Lin SH and Lee PP and Gandhi S and Chang JY and Li R and Gensheimer MF and Wakelee HA and Neal JW and Lee HS and Cheng C and Velcheti V and Lou Y and Petranovic M and Rinsurongkawong W and Le X and Rinsurongkawong V and Spelman A and Elamin YY and Negrao MV and Skoulidis F and Gay CM and Cascone T and Antonoff MB and Sepesi B and Lewis J and Wistuba II and Hazle JD and Chung C and Jaffray D and Gibbons DL and Vaporciyan A and Lee JJ and Heymach JV and Zhang J and Wu J},
  year = {2023},
  journal = {The Lancet. Digital health},
  doi = {10.1016/s2589-7500(23)00082-1},
  url = {https://doi.org/10.1016/s2589-7500(23)00082-1}
}

RIS

TY  - JOUR
TI  - Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
AU  - Saad MB
AU  - Hong L
AU  - Aminu M
AU  - Vokes NI
AU  - Chen P
AU  - Salehjahromi M
AU  - Qin K
AU  - Sujit SJ
AU  - Lu X
AU  - Young E
AU  - Al-Tashi Q
AU  - Qureshi R
AU  - Wu CC
AU  - Carter BW
AU  - Lin SH
AU  - Lee PP
AU  - Gandhi S
AU  - Chang JY
AU  - Li R
AU  - Gensheimer MF
AU  - Wakelee HA
AU  - Neal JW
AU  - Lee HS
AU  - Cheng C
AU  - Velcheti V
AU  - Lou Y
AU  - Petranovic M
AU  - Rinsurongkawong W
AU  - Le X
AU  - Rinsurongkawong V
AU  - Spelman A
AU  - Elamin YY
AU  - Negrao MV
AU  - Skoulidis F
AU  - Gay CM
AU  - Cascone T
AU  - Antonoff MB
AU  - Sepesi B
AU  - Lewis J
AU  - Wistuba II
AU  - Hazle JD
AU  - Chung C
AU  - Jaffray D
AU  - Gibbons DL
AU  - Vaporciyan A
AU  - Lee JJ
AU  - Heymach JV
AU  - Zhang J
AU  - Wu J
PY  - 2023
JO  - The Lancet. Digital health
DO  - 10.1016/s2589-7500(23)00082-1
UR  - https://doi.org/10.1016/s2589-7500(23)00082-1
ER  -

APA

MB, S., L, H., M, A., NI, V., P, C., M, S., K, Q., SJ, S., X, L., E, Y., Q, A., R, Q., CC, W., BW, C., SH, L., PP, L., S, G., JY, C., R, L., MF, G., HA, W., JW, N., HS, L., C, C., V, V., Y, L., M, P., W, R., X, L., V, R., A, S., YY, E., MV, N., F, S., CM, G., T, C., MB, A., B, S., J, L., II, W., JD, H., C, C., D, J., DL, G., A, V., JJ, L., JV, H., J, Z., & J, W. (2023). Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.. The Lancet. Digital health. https://doi.org/10.1016/s2589-7500(23)00082-1

Source records